Bionano Genomics
BNGO
27 hedge funds and large institutions have $5.65M invested in Bionano Genomics in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
185% more capital invested
Capital invested by funds: $1.98M → $5.65M (+$3.67M)
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
35% more funds holding
Funds holding: 20 → 27 (+7)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.37M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$191K |
| 3 |
VF
Virtu Financial
New York
|
+$163K |
| 4 |
Bank Julius Baer & Co
Zurich,
Switzerland
|
+$64.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$826K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$115K |
| 3 |
Barclays
London,
United Kingdom
|
-$77.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$70.9K |
| 5 |
BCM
Bayesian Capital Management
Brooklyn,
New York
|
-$51K |
BNGO Hedge Fund Activity: Q3 2020 in Review
27 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2020, worth a combined $5.65M — up 185% from $1.98M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new BNGO positions and 6 closed out — a net gain of 7 holders — while 8 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $3.37M. The largest seller was Sio Capital Management, cutting an estimated $826K.
- 27 institutional investors held Bionano Genomics (BNGO) as of Q3 2020, up from 20 in Q2 2020.
- Funds reported $5.65M of Bionano Genomics stock for Q3 2020, up 185% quarter-over-quarter.
- 13 funds opened new Bionano Genomics positions in Q3 2020 and 6 closed out, a net change of +7 holders.
- The largest Bionano Genomics buyer in Q3 2020 was Vanguard Group, an estimated $3.37M added.
- The largest Bionano Genomics seller in Q3 2020 was Sio Capital Management, an estimated $826K sold.
Based on aggregated 13F filings for Q3 2020.